美敦力

最新新闻

• 评级变动
  William Blair Maintains Medtronic(MDT.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/11
• Press Release: Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc.
  Dow Jones · 2026/10/8
• 评级变动
  A Quick Look at Today's Ratings for Medtronic(MDT.US), With a Forecast Between $95 to $115
  \u5e02\u573a\u8d44\u8baf · 2026/9/3
• 公司公告
  Medtronic | 4: Statement of changes in beneficial ownership of securities-Officer Walter Matthew R.
  SEC · 2026/7/10
• TD Cowen Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $110
  \u5e02\u573a\u8d44\u8baf · 2026/9/30
• 公司公告
  Medtronic | 4: Statement of changes in beneficial ownership of securities-Officer Blomquist Denise L.
  SEC · 2026/9/17
• 公司公告
  Medtronic | 4: Statement of changes in beneficial ownership of securities-Officer Walter Matthew R.
  SEC · 2026/6/9
• 公司公告
  Medtronic | 4: Statement of changes in beneficial ownership of securities-Officer Walter Matthew R.
  SEC · 2026/5/29
• 评级变动
  Wells Fargo Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $104
  \u5e02\u573a\u8d44\u8baf · 2026/9/10
• 评级变动
  BofA Securities Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $110
  \u5e02\u573a\u8d44\u8baf · 2026/9/14
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)
  TipRanks · 2026/9/2
• 评级变动
  UBS Maintains Medtronic(MDT.US) With Buy Rating, Raises Target Price to $110
  \u5e02\u573a\u8d44\u8baf · 2026/9/3
• 评级变动
  Needham Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $114
  \u5e02\u573a\u8d44\u8baf · 2026/9/17
• Citi Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $110
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• 公司公告
  Medtronic | 4: Statement of changes in beneficial ownership of securities-Officer Blomquist Denise L.
  SEC · 2026/6/9
• 评级变动
  J.P. Morgan Maintains Medtronic(MDT.US) With Hold Rating, Raises Target Price to $96
  \u5e02\u573a\u8d44\u8baf · 2026/9/4
• 评级变动
  A Quick Look at Today's Ratings for Medtronic(MDT.US), With a Forecast Between $95 to $118
  \u5e02\u573a\u8d44\u8baf · 2026/9/2
• Barclays Downgrades Medtronic(MDT.US) to Hold Rating, Cuts Target Price to $95
  \u5e02\u573a\u8d44\u8baf · 2026/10/8
• 评级变动
  Analysts Have Conflicting Sentiments on These Healthcare Companies: Fortrea Holdings Inc. (FTRE), Medtronic (MDT) and Immunic (IMUX)
  TipRanks · 2026/9/2
• RBC Capital Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $118
  \u5e02\u573a\u8d44\u8baf · 2026/10/3
• Medtronic Launches Exchange Offer to Complete Separation of MiniMed Group, Inc.
  PR Newswire · 2026/9/14
• 评级变动
  Citi Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $110
  \u5e02\u573a\u8d44\u8baf · 2026/9/10
• 评级变动
  TD Cowen Maintains Medtronic(MDT.US) With Buy Rating, Raises Target Price to $110
  \u5e02\u573a\u8d44\u8baf · 2026/8/28
• 评级变动
  Needham Maintains Medtronic(MDT.US) With Buy Rating, Raises Target Price to $114
  \u5e02\u573a\u8d44\u8baf · 2026/8/27
• Medtronic shares rise against the market trend as it launches the MiniMed spin-off via share exchange.
  Zhitong Finance · 9/14

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。